Iovance Biotherapeutics Appoints Athena Countouriotis, M.D., to Board of Directors Read more about Iovance Biotherapeutics Appoints Athena Countouriotis, M.D., to Board of Directors
Updated Results of Studies in Advanced Cervical Cancer and Melanoma Support Long-Term Efficacy of Iovance Tumor Infiltrating Lymphocyte (TIL) Therapy Read more about Updated Results of Studies in Advanced Cervical Cancer and Melanoma Support Long-Term Efficacy of Iovance Tumor Infiltrating Lymphocyte (TIL) Therapy
Iovance Biotherapeutics to Participate in Upcoming Conferences in June Read more about Iovance Biotherapeutics to Participate in Upcoming Conferences in June
Iovance Biotherapeutics Announces New Facility to Support U.S. Production of Tumor Infiltrating Lymphocyte Cell Therapy Products Read more about Iovance Biotherapeutics Announces New Facility to Support U.S. Production of Tumor Infiltrating Lymphocyte Cell Therapy Products
Iovance Biotherapeutics Announces Breakthrough Therapy Designation for LN-145 for Treatment of Advanced Cervical Cancer Patients Who Have Progressed on or After Chemotherapy Read more about Iovance Biotherapeutics Announces Breakthrough Therapy Designation for LN-145 for Treatment of Advanced Cervical Cancer Patients Who Have Progressed on or After Chemotherapy
Iovance Biotherapeutics Announces Updates to Tumor Infiltrating Lymphocyte (TIL) Therapy Clinical Programs Read more about Iovance Biotherapeutics Announces Updates to Tumor Infiltrating Lymphocyte (TIL) Therapy Clinical Programs
Iovance Biotherapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update Read more about Iovance Biotherapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update
Iovance Biotherapeutics to Participate in Upcoming Conferences in May Read more about Iovance Biotherapeutics to Participate in Upcoming Conferences in May
Iovance Biotherapeutics to Host First Quarter 2019 Financial Results Conference Call and Webcast on Tuesday, May 7, 2019 Read more about Iovance Biotherapeutics to Host First Quarter 2019 Financial Results Conference Call and Webcast on Tuesday, May 7, 2019
Athena Countouriotis, MD Member of the Nominating and Corporate Governance CommitteeMember of the Compensation Committee Athena Countouriotis, MD Director